2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery: Developed by the task force for cardiovascular …

S Halvorsen, J Mehilli, S Cassese, TS Hall… - European heart …, 2022 - academic.oup.com
Off-label use of medication may be presented in these guidelines if a sufficient level of
evidence shows that it can be considered medically appropriate to a given condition and if …

Tricuspid regurgitation: recent advances in understanding pathophysiology, severity grading and outcome

RT Hahn, LP Badano, PE Bartko… - European Heart …, 2022 - academic.oup.com
Heightened interest in tricuspid regurgitation (TR) stems from the consistent association of
mortality with greater severity of TR, and a low use of surgical solutions in the setting of high …

[HTML][HTML] Edoxaban versus vitamin K antagonist for atrial fibrillation after TAVR

NM Van Mieghem, M Unverdorben… - … England Journal of …, 2021 - Mass Medical Soc
Background The role of direct oral anticoagulants as compared with vitamin K antagonists
for atrial fibrillation after successful transcatheter aortic-valve replacement (TAVR) has not …

[HTML][HTML] Concomitant tricuspid repair in patients with degenerative mitral regurgitation

JS Gammie, MWA Chu, V Falk… - … England Journal of …, 2022 - Mass Medical Soc
Background Tricuspid regurgitation is common in patients with severe degenerative mitral
regurgitation. However, the evidence base is insufficient to inform a decision about whether …

TRI-SCORE: a new risk score for in-hospital mortality prediction after isolated tricuspid valve surgery

J Dreyfus, E Audureau, Y Bohbot, A Coisne… - European Heart …, 2022 - academic.oup.com
Aims Isolated tricuspid valve surgery (ITVS) is considered to be a high-risk procedure, but in-
hospital mortality is markedly variable. This study sought to develop a dedicated risk score …

Apixaban vs. standard of care after transcatheter aortic valve implantation: the ATLANTIS trial

JP Collet, E Van Belle, H Thiele, S Berti… - European heart …, 2022 - academic.oup.com
Aims The respective roles of oral anticoagulation or antiplatelet therapy following
transcatheter aortic valve implantation (TAVI) remain debated. ATLANTIS is an international …

Self-expanding transcatheter vs surgical aortic valve replacement in intermediate-risk patients: 5-year outcomes of the SURTAVI randomized clinical trial

NM Van Mieghem, GM Deeb, L Søndergaard… - JAMA …, 2022 - jamanetwork.com
Importance In patients with severe aortic valve stenosis at intermediate surgical risk,
transcatheter aortic valve replacement (TAVR) with a self-expanding supra-annular valve …

Sex differences and similarities in valvular heart disease

JT DesJardin, J Chikwe, RT Hahn, JW Hung… - Circulation …, 2022 - Am Heart Assoc
As populations age worldwide, the burden of valvular heart disease has grown
exponentially, and so has the proportion of affected women. Although rheumatic valve …

The society of thoracic surgeons adult cardiac surgery database: 2022 update on outcomes and research

KM Kim, A Arghami, R Habib, MA Daneshmand… - The Annals of Thoracic …, 2023 - Elsevier
The Society of Thoracic Surgeons Adult Cardiac Surgery Database is the most mature and
comprehensive cardiac surgery database. It is one of the most respected clinical data …

Restoring sinus rhythm reverses cardiac remodeling and reduces valvular regurgitation in patients with atrial fibrillation

L Soulat-Dufour, S Lang, K Addetia, S Ederhy… - Journal of the American …, 2022 - jacc.org
Background Cardiac chamber remodeling in atrial fibrillation (AF) reflects the progression of
cardiac rhythm and may affect functional regurgitation. Objectives The purpose of this study …